Summary
[3H]-(-)-Dihydroalprenolol ([3H]-DHA) binds to rat spleen membranes with a dissociation equilibrium constant (K D) of about 0.7 nM and a maximal number of binding sites of 272 fmoles x mg protein−1. Approximately 90% of the sites labelled by 1 nM [3H]-DHA possess classical properties of beta-adrenoceptors. The labelled ligand is stereospecifically displaced by the isomers of propranolol and the order of potency of agonists is: isoprenaline>adrenaline >noradrenaline. Highly selective beta1 antagonists such as practolol and atenolol displaced [3H]-DHA from spleen membranes in a biphasic manner indicating the co-existence of beta1 and beta2 sites (30–35% beta1; 65–70% beta2) in this tissue. Support for this classification was provided by the binding of the beta2 agonist procaterol to spleen membranes. This drug possessed high affinity only for those sites that have low affinity for the beta1, selective agents.
Chemical sympathectomy induced by chronic 6-hydroxydopamine administration did not alter the number or the pharmacological properties of beta-adrenoceptor binding sites. The results suggest that both beta1 and beta2 adrenoceptors are probably postsynaptic in spleen.
Similar content being viewed by others
References
Ahlquist, R. P., Taylor, J. P., Rawson, C. V., Sydow, V. L.: Comparative effects of epinephrine and levarterenol in the intact anesthetized dog. J. Pharmacol. Exp. Ther. 110, 352–360 (1954)
Anton, A. H., Sayre, D. F.: A study of the factors affecting the aluminium oxide-trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther. 138, 360–373 (1962)
Barnett, D. B., Rugg, E. L., Nahorski, S. R.: Direct evidence for two types of beta-adrenoceptor binding sites in lung tissue. Nature 273, 166–167 (1978)
Bickerton, R. K., Rockhold, W. T., Micalizzi, E. R.: Use of isolated strips of cat spleen for the assay of alpha-adrenergic blocking compounds. J. Pharm. Sci. 51, 837–840 (1962)
Ignarro, L. J., Titus, E.: The presence of antagonistically acting alpha and beta adrenergic receptors in mouse spleen. J. Pharmacol. Exp. Ther. 160, 72–80 (1968)
Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. S., Brown, T. G.: Differentiation of receptor systems activated by sympathomimetic agents. Nature 214, 597–599 (1967)
Langer, S. Z.: Presynaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmacol. 60, 481–497 (1977)
Langer, S. Z., Dubocovich, M. L.: Physiological and pharmacological relevance of presynaptic beta-adrenoceptors in modulating transmitter release. In: Recent advances in the pharmacology of adrenoceptors (E. Szabadi, C. M. Bradshaw and P. Bevan, eds.), pp. 181–189. Elsevier: North-Holland Biomedical Press 1978
Lowry, O. W., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurements with the folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)
Maguire, M. E., Ross, E. M., Gilman, A. G.: β-Adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase. In: Advances in cyclic nucleotide research, Vol. 8, (P. Greengard, and G. A. Robison, eds.), pp. 1–83. New York: Raven Press 1977
Nahorski, S. R.: Heterogeneity of cerebral beta-adrenoceptor binding sites in various vertebrate species. Eur. J. Pharmacol. 51, 199–209 (1978)
Nahorski, S. R., Willcocks, A. L.: Identification of β-adrenoceptor subtypes in various regions of the rat brain. In: Recent advances in the pharmacology of adrenoceptors (E. Szabadi, C. M. Bradshaw, and P. Bevan, eds.) pp. 347–348. Elsevier: North-Holland Biomedical Press 1978
Ottis, K., Davis, J. E., Green, H. D.: Effects of adrenergic and cholinergic drugs on splenic inflow and outflow before and after adrenergic blockade. Am. J. Physiol. 189, 599–604 (1957)
Richardson, A., Nahorski, S. R.: Direct identification of the β-adrenoceptor in rat uterus. In: Recent advances in the pharmacology of adrenoceptors (E. Szabadi, C. M. Bradshaw, and P. Bevan, eds.), pp. 335–336. Elsevier: North-Holland Biomedical Press 1978
Rugg, E. L., Barnett, D. B., Nahorski, S. R.: Co-existence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies. Mol. Pharmacol. 14, 996–1005 (1978)
Sharma, V. K., Banerjee, S. P.: Presynaptic alpha, beta adrenergic and muscarinic cholinergic receptors in rat peripheral tissues. Fed. Proc. 37, 346 (1978)
Shellenberger, M. K. Gordon, J. H.: A rapid simplified procedure for simultaneous assay of norepinephrine, dopamine and 5-hydroxytryptamine from discrete brain regions. Anal. Biochem. 39, 356–367 (1971)
Starke, K.: Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77, 1–82 (1977)
Thoenen, H., Tranzer, J. P.: Chemical sympathectomy by selective destruction of noradrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedeberg's Arch. Pharmacol. Exp. Path. 261, 271–288 (1968)
Wolfe, B. B., Harden, K. T., Molinoff, P. B.: In vitro study of β-adrenergic receptors. Ann. Rev. Pharmacol. Toxicol. 17, 575–604 (1977)
Yabucchi, Y.: The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations. Br. J. Pharmacol. 61, 513–521 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nahorski, S.R., Barnett, D.B., Howlett, D.R. et al. Pharmacological characteristics of beta-adrenoceptor binding sites in intact and sympathectomized rat spleen. Naunyn-Schmiedeberg's Arch. Pharmacol. 307, 227–233 (1979). https://doi.org/10.1007/BF00505938
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00505938